Halo Pharmaceutical, Inc.
12 articles about Halo Pharmaceutical, Inc.
-
Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit
11/2/2023
Noramco, a leading global active pharmaceutical ingredients manufacturer, specializing in controlled substances, announced it has completed the acquisition of the Cambrex Drug Product Business Unit previously known as Halo Pharmaceuticals.
-
Halo Pharma Simplifies Topical Drug Product Development and Manufacturing
4/12/2018
Global Pharmaceutical Companies Outsource Topical Products to Halo Pharma
-
Halo Pharmaceutical, Inc. Makes Donation To American Red Cross And Encourages Others To Help Those Affected By Hurricanes Harvey And Irma
9/13/2017
-
Halo Pharmaceutical, Inc. Welcomes Itzhak Krinsky, Ph.D. To Its Board Of Directors
6/27/2017
-
Halo Pharmaceutical, Inc. Welcomes Itzhak Krinsky, Ph.D. To Its Board Of Directors
6/27/2017
-
Halo Pharmaceutical, Inc. Announces The Formation Of Its Pediatric Center Of Excellence For The Development, Reformulation, And Manufacturing Of Drug Products In Pediatric Dosage Forms
5/10/2017
-
Halo Pharmaceutical, Inc. And ExxPharma Therapeutics To Collaborate On The Development/Manufacturing Of Products Using Twin Screw Extrusion Technology
4/14/2016
-
Halo Pharmaceutical, Inc. Makes Key Additions To Management Team
8/27/2015
-
Halo Pharmaceutical, Inc. Welcomes Dr. George Bobotas as Its Chief Scientific Officer
4/21/2009
-
Halo Pharmaceutical, Inc. Launches a Branded Product Marketing Company in Canada
3/3/2009
-
Halo Pharmaceutical, Inc. Welcomes Al Rosenston as its Vice President, Business Development
1/27/2009
-
Halo Pharmaceutical, Inc. Acquires Whippany Manufacturing Facility from Abbott Laboratories
1/7/2009